ReviewPharmaceutics2022

Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy.

Josef Jampilek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.